After treatment, laryngeal and bronchial thresholds were significantly improved in all the classes, particularly in the PR/CRS class (Table V). Cough was improved or resolved in 105 (95%) of the patients with PR/CRS, in 11 (79%) of the patients with GERD, and in only 18 (36%) of the patients with UNEX